Furthermore, the interaction of SARS-CoV-2 with endothelial cells in the lung, particularly those with overexpressed angiotensin-converting enzyme 2 (ACE2), could exacerbate the risk of coagulopathies by inducing a pro-coagulative and inflammatory state (17–21). Here, ACE2 is linked to blood coagulation disease.